C2 deficiency is one of the most common inherited
complement component deficiency. It may occur in asymptomatic individuals but it is frequently associated with autoimmune manifestations, particularly with discoid or
systemic lupus erythematosus. Approximately 40% of the patients with C2 deficiency develop SLE or discoid lupus and aproximately 50% develop recurrent infections. Patients with C2 deficiency express many of the characteristic features of lupus, but severe nephritis, cerebritis, and aggressive arthritis are less common than in complement sufficient SLE patients. Cutaneous lesions are common in C2 deficiencient patients with lupus, and many have a characteristic annular photosensitive rash. C2 deficiency patients have also other reumathic disordes as glomerulonephritis, dermatomyositis, anaphylactoid purpura, and vasculitis. The bacterial infections are usually systemic infections (e.g. sepsis and meningitis) with encapsulated organisms (Pneumococcus and H.influenzae) and more common in childhood.
Diagnosis
Diagnostic recommendations
Additional Information
Diagnostic laboratories
Clinical:
Genetic:
Therapeutic options
- No specific treatment is available for C2 deficiency. Prevention and acute treatment of infections are essential; infusion of fresh frozen plasma can be used for emergency replacement of C2 component. Meningococcal, pneumococcal, and haemophilus vaccinations are recommended.
- Complement deficiency, eMedicine
- Complement deficiency, eMedicine